EARLY DETECTION AND MANAGEMENT STRATEGIES OF CHRONIC KIDNEY DISEASE

Authors

  • Tusunova Gulasal Jasurbek qizi Email: tursunovagulasal2@gmail.com Tel: +998942790788
  • Davronbekova Zarifaxon Davronbek qizi Email: davronbekovazarifa1@gmail.com Tel: +998889865606
  • Mahammadjonov Saidjahon Shokirjon o‘g‘li Email: mahammadjonovsaidjahon0701@gmail.com Tel: +998940320710 Kokand University, Andijan Branch Faculty of Medicine “General Medicine” Direction, 1st-Year Students, Group 25–35

Abstract

Chronic Kidney Disease (CKD) is a progressive condition characterized by a gradual loss of kidney function over time. Early detection of CKD is essential for preventing severe complications such as end-stage renal failure and cardiovascular diseases. This study focuses on identifying early diagnostic markers, including serum creatinine levels, glomerular filtration rate (GFR), and urinary albumin excretion. The research also examines effective management strategies such as lifestyle modifications, pharmacological interventions, and regular monitoring to slow disease progression. Implementing early screening programs and raising public awareness can significantly reduce the burden of CKD and improve patients’ quality of life.

References

1. Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2022 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International, 2022.

2. National Kidney Foundation (NKF). KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. American Journal of Kidney Diseases, 2020.

3. World Health Organization (WHO). Global Report on Kidney Health: Reducing the Burden of Chronic Kidney Disease. Geneva, 2023.

4. Levey, A.S., Coresh, J. Chronic Kidney Disease. The Lancet, 2012; 379(9811):165–180.

5. Jha, V., Garcia-Garcia, G., Iseki, K., et al. Chronic kidney disease: global dimension and perspectives. The Lancet, 2013; 382(9888): 260–272.

6. Webster, A.C., Nagler, E.V., Morton, R.L., Masson, P. Chronic Kidney Disease. The Lancet, 2017; 389(10075):1238–1252.

7. Eckardt, K.U., Coresh, J., Devuyst, O., et al. Evolving importance of kidney disease: from subspecialty to global health burden. The Lancet, 2013; 382(9887):158–169.

8. James, M.T., Hemmelgarn, B.R., Tonelli, M. Early recognition and prevention of chronic kidney disease. The Lancet, 2010; 375(9722):1296–1309.

9. Tuttle, K.R., Bakris, G.L., Bilous, R.W., et al. Diabetic kidney disease: a report from an ADA consensus conference. Diabetes Care, 2014; 37(10):2864–2883.

10. Wouters, O.J., O’Donoghue, D.J., Ritchie, J., Kanavos, P., Narva, A.S. Early chronic kidney disease: diagnosis, management and models of care. Nature Reviews Nephrology, 2015; 11(8):491–502.

11. Glassock, R.J., Warnock, D.G., Delanaye, P. The global burden of chronic kidney disease: estimates, variability and pitfalls. Nature Reviews Nephrology, 2017; 13(2):104–114.

12. Lv, J., Zhang, L. Prevention and treatment of chronic kidney disease in developing countries. Nature Reviews Nephrology, 2019; 15(9):555–573.

13. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Chronic Kidney Disease (CKD) Overview. U.S. Department of Health and Human Services, 2021.

14. Hill, N.R., Fatoba, S.T., Oke, J.L., et al. Global prevalence of chronic kidney disease: a systematic review and meta-analysis. PLoS ONE, 2016; 11(7): e0158765.

15. Chen, T.K., Knicely, D.H., Grams, M.E. Chronic Kidney Disease Diagnosis and Management: A Review. JAMA, 2019; 322(13):1294–1304.

Downloads

Published

2025-11-03

How to Cite

Tusunova Gulasal Jasurbek qizi, Davronbekova Zarifaxon Davronbek qizi, & Mahammadjonov Saidjahon Shokirjon o‘g‘li. (2025). EARLY DETECTION AND MANAGEMENT STRATEGIES OF CHRONIC KIDNEY DISEASE. Modern World Education: New Age Problems – New Solutions, 2(11), 218–222. Retrieved from https://incop.org/index.php/mo/article/view/2371